Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics.
about
Sex differences in the brain: a whole body perspectivePharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringSystemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of RodentsEffect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosisSex differences in liver toxicity-do female and male human primary hepatocytes react differently to toxicants in vitro?Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice.Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3Evaluation of sexual dimorphism in the efficacy and safety of simvastatin/atorvastatin therapy in a southern Brazilian cohort.Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone.HNF4α--role in drug metabolism and potential drug target?Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands.Inverted expression profiles of sex-biased genes in response to toxicant perturbations and diseases.Limited sampling strategy of partial area under the concentration-time curves to estimate midazolam systemic clearance for cytochrome P450 3A phenotyping.Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice.The effect on potential adverse drug events of a pharmacist-acquired medication history in an emergency department: a multicentre, double-blind, randomised, controlled, parallel-group studySex and gender differences in health. Science & Society Series on Sex and Science.Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials.Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.Gender-based personalized pharmacotherapy: a systematic review.Therapeutic implications of the gender-specific aspects of cardiovascular disease.Phthalate diesters and their metabolites in human breast milk, blood or serum, and urine as biomarkers of exposure in vulnerable populations.Sex differences in pharmacokinetics and toxicity of antiretroviral therapy.Gender differences in chemical carcinogenesis in National Toxicology Program 2-year bioassays.Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymesParticipation of women and sex analyses in late-phase clinical trials of new molecular entity drugs and biologics approved by the FDA in 2007-2009.Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs.Gender differences in the adverse events' profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis.Sex differences in the expression of hepatic drug metabolizing enzymes.A pharmacokinetic/pharmacodynamic model of tumor lysis syndrome in chronic lymphocytic leukemia patients treated with flavopiridol.Considering Sex as a Biological Variable Will Be Valuable for Neuroscience ResearchGender and interindividual variability in pharmacokinetics.The challenges of including sex/gender analysis in systematic reviews: a qualitative surveySex and sensitivity: the continued need for sex-based biomedical research and implementation.Differences between Japan and the United States in dosages of drugs recently approved in Japan.Sex differences in pharmacokinetics of antidepressants.Influence of sex on treatment and outcome in chronic heart failure.Gender differences in the primary prevention of stroke with aspirin.Adverse effects in women: implications for drug development and regulatory policies.
P2860
Q26798004-0A4C7366-0F7B-4C1F-9801-8FB8C3180D1BQ27027293-0AF27470-B1BD-492B-AB97-12998B35B2C0Q27301271-CE63A626-1B81-4E4F-82FC-20C5BB86028DQ28211897-56CC8A64-8F4B-49FC-AE4C-6C2886170B41Q28545829-4FCB49F4-457D-42A4-B14E-4547120709F6Q33574954-08C59D3D-F61D-4C75-92B0-C2A07AD580DDQ33710324-0859FE21-2F82-452C-8526-DB2DE25DCDFBQ34020658-06DE714C-19E8-4D4C-B558-804B34623E22Q34243889-3EACAD06-4A02-4707-BA65-E030840F6CB2Q34290581-19221F65-49C8-470C-802E-6F6F8F48626DQ34311568-299B006B-BF08-4A6C-BB6E-411140394A5CQ34476110-7EAA88E5-4F3C-48E6-9743-F930496A136BQ34606983-B2E2B438-199C-4AE3-9FD7-947A82DC102DQ34810573-AD87B3A6-2D5F-4D41-8D04-A7D91C8011F6Q35551006-F08E2132-464B-4106-8731-B7793EF50104Q35750790-082B0098-7EE4-4C64-BEA9-05C9337B0705Q36073394-F20939A8-2A8C-4584-ABCC-7C25670B9BC4Q36204611-BCB9CBD6-DEEA-41CD-9F08-E944467B9522Q36218118-4D2D5396-D29C-4717-A222-BBEB17F94874Q36335289-4B7B739B-9638-4C79-885E-C827C0A7E98DQ36467824-6CF4074E-3053-4EE5-8062-BA0F53A53FE5Q36490867-5DB3AE03-C853-4748-BDB7-484E83800D86Q36546272-EAFDD01B-1D4E-4D72-BAC5-E0DF42EF9FE0Q36653415-91660FDF-D5A6-4610-9922-3C1D3DC18274Q36939547-28D838DD-AEF0-416B-8B72-83E227743386Q36991121-48C6B2FC-DCFE-47CF-990A-C315272C3ED0Q37020195-F6896344-694B-445A-A23A-055A6AEC6F56Q37256195-87BC0500-E9D7-495F-9694-549BE03624C2Q37265697-0B82143B-205B-4602-9E97-1C4D915920E4Q37268108-1AB81779-13A4-4414-A3E7-4F8FA34F39A2Q37354482-8FEF9CB6-9611-4999-9E94-6707670EE1B5Q37445074-E0EE86D5-3DE2-4CCB-A976-4FD8ABFC8297Q37550556-6A12D6E2-B2E5-4A58-8693-41077D8E0C68Q37708570-DC942A8D-E4E1-4069-B259-D4F452711380Q37769521-6430B5F8-D6E7-4F31-B7D5-9D462FE03286Q37772373-20C36EAD-C209-46EB-B786-CB8F7DBA043EQ37824711-C1187C99-AFB2-42B9-ACEE-EAFF82A11454Q37877792-9E035309-080D-4786-9C5A-EC6547DFA411Q37879676-7B11BF1C-D221-4E59-B10E-B1B225497F40Q37960526-E92F8B37-AE65-4CC9-B041-71E4C1A26E78
P2860
Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Sex and racial differences in ...... inetics, and pharmacodynamics.
@ast
Sex and racial differences in ...... inetics, and pharmacodynamics.
@en
type
label
Sex and racial differences in ...... inetics, and pharmacodynamics.
@ast
Sex and racial differences in ...... inetics, and pharmacodynamics.
@en
prefLabel
Sex and racial differences in ...... inetics, and pharmacodynamics.
@ast
Sex and racial differences in ...... inetics, and pharmacodynamics.
@en
P356
P1476
Sex and racial differences in ...... inetics, and pharmacodynamics.
@en
P2093
Gail D Anderson
P356
10.1089/JWH.2005.14.19
P577
2005-01-01T00:00:00Z